Choline

Gut Microbe Molecule TMA Inhibits IRAK4, Easing Diet-Driven Inflammation in Diabetes Models

The Nature Metabolism study spotlights IRAK4 as a drug target, with microbiome-informed nutrition proposed for future testing.